10% Owner Insight Venture Partners Files Intent to Sell $48M in Hinge Health Stock
HNGE has more than doubled off its 52-week low of $30.08 on elevated volume (2.6× avg).
Summary
A major institutional investor, Insight Venture Partners, plans to sell $48 million in Hinge Health stock, adding to recent insider selling activity.
Key Events · Ownership and Investor Activity · HNGE
-
Intent to Sell Significant Stake
Insight Venture Partners, a 10% stockholder, filed a Form 144 to sell 600,613 shares of Class A Common stock, valued at approximately $48.05 million.
-
Follows Recent Sales
This filing indicates an ongoing pattern of sales by Insight Venture Partners, which has already sold 600,613 shares for $42.81 million in the past three months.
-
Stock Trading Near 52-Week High
The proposed sale occurs as Hinge Health's stock is trading near its 52-week high of $84.62, potentially allowing the investor to lock in gains.
-
Part of Broader Insider Distribution
This transaction contributes to a net insider selling trend of nearly $97.5 million in open-market transactions over the last 90 days.
Analysis · HNGE · Technology
Insight Venture Partners, a 10% institutional shareholder, has filed a Form 144 indicating its intent to sell approximately $48 million worth of Hinge Health Class A Common stock. This follows recent sales by the same entity and contributes to a broader pattern of insider distribution, occurring while the stock trades near its 52-week high.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 29.5% of the 1672 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.22%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HNGE was trading at $81.00 on NYSE in the Technology sector, with a market capitalization of approximately $6.3B. The 52-week trading range was $30.08 to $84.62. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.